The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INTACT: Phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle invasive bladder cancer—SWOG/NRG1806.
 
Parminder Singh
Consulting or Advisory Role - Genentech/Roche; Pfizer; Prometheus
 
Cathy Tangen
No Relationships to Disclose
 
Jason A. Efstathiou
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Janssen; Taris BioMedical
 
Seth P. Lerner
Honoraria - Dava Oncology; MSD; Nucleix
Consulting or Advisory Role - Anchiano; Ferring; Merck Sharp & Dohme; miR Scientific; QED Therapeutics; Roche/Genentech; Urogen pharma; Vaxiion; Verity Pharmaceuticals
Research Funding - Endo Pharmaceuticals; FKD Therapies; Japan BCG Laboratory; Roche/Genentech; Urogen pharma; Vaxiion; Viventia Biotech
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Travel, Accommodations, Expenses - Dava Oncology; Ferring; MSD; Nucleix
 
Sameer G. Jhavar
No Relationships to Disclose
 
Noah M. Hahn
Honoraria - Bladder Cancer Academy; PeerView; PlatformQ Health
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Champions Oncology; CicloMed; Ferring; Genentech/Roche; GlaxoSmithKline; Health Advances; Incyte; Inovio Pharmaceuticals; Janssen; Merck; Mirati Therapeutics; Pieris Pharmaceuticals; Principa Biopharma; Rexahn Pharmaceuticals; Seattle Genetics/Astellas; Taris BioMedical; Trans Med
Research Funding - Acerta Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Pieris Pharmaceuticals (Inst); Principa Biopharma (Inst); Seattle Genetics/Astellas (Inst)
 
Brian Addis Costello
Research Funding - GlaxoSmithKline/Novartis (Inst)
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Janssen (Inst)
 
Weliang Du
No Relationships to Disclose
 
Joshua J. Meeks
Honoraria - CG Oncology; Janssen
Consulting or Advisory Role - AstraZeneca; Ferring; Merck
Research Funding - Epizyme; Merck Sharp & Dohme
Travel, Accommodations, Expenses - AstraZeneca; Merck Sharp & Dohme
 
Bishoy Morris Faltas
Honoraria - Digital Science Press
Research Funding - Lilly
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Driver, Inc; EMD Serono; Exelixis; Foundation Medicine; Genzyme; GlaxoSmithKline; HERON; Janssen; Merck; Mirati Therapeutics; Pfizer; QED Therapeutics; Roche; Seagen
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Immunomedics (Inst); Pfizer (Inst)
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; PFS Genomics; SerImmune
Honoraria - Genentech
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Celgene; EMD Serono; Genzyme; Janssen Biotech; Medivation/Astellas
Research Funding - Zenith Epigenetics
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Ronald C. Chen
Consulting or Advisory Role - Accuray; Bayer; Blue Earth Diagnostics; Medivation/Astellas
Research Funding - Accuray
 
Alicia K. Morgans
Honoraria - Astellas Pharma; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Genentech; Janssen; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genentech; Janssen; Sanofi
Research Funding - AstraZeneca; Bayer; Genentech; Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Sanofi
 
Amit Gupta
No Relationships to Disclose
 
Richard Carlton Bangs
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - American Institutes for Research; Facing our Risk of Cancer Empowered; National Cancer Institute; National Cancer Institute; NCI; Summa Health System; SWOG; SWOG; University of Puerto Rico; University of Puerto Rico
 
Kathryn A. Winter
No Relationships to Disclose
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Novartis; Pfizer; UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Caris Life Sciences; Clovis Oncology; Corvus Pharmaceuticals; Eisai; Genentech/Roche; Janssen Oncology; Merck; Modra Pharmaceuticals; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Genentech/Roche; Sanofi
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst)
Expert Testimony - Novartis
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; Sanofi/Aventis; US Oncology
 
Ian Murchie Thompson
Consulting or Advisory Role - Magforce; Profound Medical; Rapamycin Holdings
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme